Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hard-to-treat lung cancer? early trial combines two drugs to fight recurrence.

NCT ID NCT07550842

First seen May 07, 2026 · Last updated May 23, 2026 · Updated 4 times

Summary

This early-phase study tests a new drug (BL0020) combined with an immunotherapy (Toripalimab) in about 33 adults with extensive-stage small cell lung cancer that returned after first treatment. The main goals are to find a safe dose and see if the combo can shrink tumors. This is not a cure, but aims to better control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL CARCINOMA OF LUNG are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, 150081, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, 450008, China

  • Shanghai Chest Hospital

    Shanghai, 200030, China

  • Shanghai Pulmonary Hospital

    Shanghai, 200433, China

  • Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang, 317000, China

  • The First Hospital of China Medical University

    Shenyang, Liaoning, 110001, China

  • The First People's Hospital of Changzhou

    Changzhou, Jiangsu, 213003, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

Conditions

Explore the condition pages connected to this study.